Furthermore, the level of LINC00870 is higher in the plasma and sputum obtained from TB and LTBI patients and decreases after 3 months of anti-TB therapy (ATT), showing the potential of being a biomarker for the diagnosis and treatment evaluation of TB (159). Here, LINC00870 is linked to tuberculosis.